VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

Valtoco(®) is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older. Although IV and rectal diazepam are already used to treat seizure clusters, Valt...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Int
Autors principals: Cornett, Elyse M., Amarasinghe, Sam N., Angelette, Alexis, Abubakar, Tunde, Kaye, Adam M., Kaye, Alan David, Neuchat, Elisa E., Urits, Ivan, Viswanath, Omar
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931041/
https://ncbi.nlm.nih.gov/pubmed/33670456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/neurolint13010007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars